As per the latest Enforcement Report of US Food and Drug Administration, the Mumbai-headquartered Sun Pharmaceutical ...

Dr Reddy’s Laboratories invests Rs 565 crore in Russian subsidiary, acquiring 45.19% stake for working capital needs.

Indian pharmaceutical giants Sun Pharma, Lupin and Dr Reddy's Laboratories are recalling drugs from the US market due to ...

Indian pharmaceutical companies Sun Pharma, Lupin, and Dr Reddy's Laboratories are conducting recalls in the US due to ...

Sun Pharmaceutical Industries, headquartered in Mumbai, is recalling 5,448 bottles of a generic drug used to treat Attention ...

Indian pharmaceutical companies Sun Pharma, Lupin, and Dr Reddy's Laboratories are recalling some of their medicines from the ...

Three major Indian pharmaceutical companies are recalling drugs in the United States. Sun Pharma is recalling ...

Top pharma players Dr Reddy, Lupin, and Sun Pharma are reportedly recalling drugs from the US market as a result of manufacturing faults an product mix up, as per the US Food and Drug Administration ...

EMA recommends Gilead Sciences' Lenacapavir for HIV prevention, with FDA approval and generic options available soon.

Sun Pharma, Lupin and Dr Reddy's Laboratories are recalling various drugs in the US due to manufacturing issues and product mix-ups, as reported by the US health regulator.

TVS Motor Company invests record Rs ₹1,025 crore in R&D in FY25, achieving highest-ever revenue and profit in history.